These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3059060)

  • 1. Antiestrogen binding sites: general and comparative properties.
    Lazier CB; Bapat BV
    J Steroid Biochem; 1988 Oct; 31(4B):665-9. PubMed ID: 3059060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
    Watts CK; Sutherland RL
    Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High affinity specific antiestrogen binding sites are concentrated in rough microsomal membranes of rat liver.
    Watts CK; Sutherland RL
    Biochem Biophys Res Commun; 1984 Apr; 120(1):109-15. PubMed ID: 6712683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of oxygenated cholesterol metabolites to antiestrogen binding sites from chicken liver.
    Murphy PR; Breckenridge WC; Lazier CB
    Biochem Biophys Res Commun; 1985 Mar; 127(3):786-92. PubMed ID: 3985957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen binding sites in rat liver nuclei.
    Kon OL
    Biochim Biophys Acta; 1985 Dec; 843(3):245-53. PubMed ID: 4063396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine antiestrogen-binding protein: characterization, solubilization and modulation by lipids.
    Matin A; Hwang PL; Kon OL
    Biochim Biophys Acta; 1987 Dec; 931(3):364-75. PubMed ID: 3676352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat.
    Sudo K; Monsma FJ; Katzenellenbogen BS
    Endocrinology; 1983 Feb; 112(2):425-34. PubMed ID: 6848356
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
    Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.
    Gulino A; Vacca A; Modesti A; Screpanti I; Farina A; Frati L
    Biochem Pharmacol; 1986 Nov; 35(21):3863-70. PubMed ID: 3778510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and antiestrogen binding sites in desmoid tumors.
    Lim CL; Walker MJ; Mehta RR; Das Gupta TK
    Eur J Cancer Clin Oncol; 1986 May; 22(5):583-7. PubMed ID: 3770030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of antiestrogen binding sites in human endometrial cancer cells.
    Hayashida M; Terakawa N; Shimizu I; Ikegami H; Wakimoto H; Aono T; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1987 Jun; 26(6):705-11. PubMed ID: 3613570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesis.
    Teo CC; Kon OL; Sim KY; Ng SC
    J Med Chem; 1992 Apr; 35(8):1330-9. PubMed ID: 1573630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The occurrence of estrogen and progestin receptors and anti-estrogen binding sites (AEBS) in canine non-Hodgkin's lymphomas.
    Teske E; Besselink CM; Blankenstein MA; Rutteman GR; Misdorp W
    Anticancer Res; 1987; 7(4B):857-60. PubMed ID: 3674774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
    Sheen YY; Simpson DM; Katzenellenbogen BS
    Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
    Murphy PR; Butts C; Lazier CB
    Endocrinology; 1984 Jul; 115(1):420-6. PubMed ID: 6734522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of the microsomal tamoxifen binding site.
    Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
    J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
    de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity cytosol binding site(s) for antiestrogens in two human breast cancer cell lines and in biopsy specimens devoid of estrogen receptors.
    Chouvet C; Saez S
    J Steroid Biochem; 1984 Dec; 21(6):755-61. PubMed ID: 6527539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.